PROGNOSTIC VALUE OF CACHEXIA INDEX DETERMINED BY BIOELECTRICAL IMPEDANCE ANALYSIS IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS UNDERGOING R-CHOP CHEMOTHERAPY
EHA Library, Young Hoon Park, 421788
TWENTY-YEAR SINGLE-CENTER EXPERIENCE TREATING PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): ADMINISTER BEST THERAPY FIRST
EHA Library, Sotirios Bristogiannis, 421789
PATTERNS OF PRIMARY LARGE B CELL TESTICULAR LYMPHOMA RELAPSES IN THE RITUXIMAB ERA
EHA Library, Suheil Albert Atallah-Yunes, 421790
THE DISPARITY OF CIRCULATING IMMUNE CELL SUBSETS AND INFLAMMATORY STATUS BETWEEN HIV-POSITIVE AND HIV-NEGATIVE PATIENTS WITH LYMPHOMA
EHA Library, Qing Xiao, 421791
EFFICACY AND SAFETY OF MECAPEGFILGRASTIM IN PREVENTING CHEMOTHERAPY-INDUCED NEUTROPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Ting Niu, 421792
CYCLOPHOSPHAMIDE, MITOXANTRONE HYDROCHLORIDE LIPOSOME, VINCRISTINE, AND PREDNISONE REGIME WITH OR WITHOUT RITUXIMAB (CMOP±R) SHOWS HIGH EFFICACY AS A FIRST-LINE TREATMENT FOR NON-HODGKIN'S LYMPHOMA
EHA Library, Tao You, 421793
ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF UNTREATED NON-GERMINAL CENTER B-CELL SUBTYPE DIFFUSE LARGE B-CELL LYMPHOMA WITH MULTIPLE EXTRANODAL INVOLVEMENT.
EHA Library, Caixia Li, 421794
BASELINE MONOCYTE-TO-PLATELETS RATIO (MPR) IS ASSOCIATED WITH INFERIOR PROGRESSION-FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA: A MULTI-CENTER REAL-LIFE SURVEY
EHA Library, Andrea Duminuco, 421795
PRELIMINARY INVESTIGATION OF THE EFFICACY AND SAFETY OF ZANUBRUTINIB IN COMBINATION WITH R-CHEMO AS FIRST-LINE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA
EHA Library, Haiwen Huang, 421796
XPO-1 INHIBITOR SELINEXOR IN COMBINATION WITH RCHOP IS AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH DOUBLE/TRIPLE-HIT LARGE B-CELL LYMPHOMA.
EHA Library, Haiyan Yang, 421797
INCIDENCE, PREVALENCE AND TRENDS OF B CELL LYMPHOMA IN URBAN CHINA: A NATIONWIDE POPULATION-BASED STUDY
EHA Library, Yinchu Cheng, 421799
DIFFERENT SUBTYPE OF DLBCL PATIENTS TREATED WITH R-CHOP(LIKE) PLUS ORELABRUTINIB REGIMEN: A REAL-WORLD STUDY
EHA Library, Wei Xu, 421800
LINPERLISIB IN COMBINATION WITH CHOP FOR NEWLY-DIAGNOSED PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY RESULTS FROM THE PHASE 1B/2 LINCH STUDY
EHA Library, Qingqing Cai, 421801
ORELABRUTINIB, RITUXIMAB AND HIGH-DOSE METHOTREXATE (HD-MTX) IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE ANALYSIS ON EFFICACY AND SAFETY
EHA Library, Shujuan Wen, 421802
CHIDAMIDE IN COMBINATION WITH R-CHOP-LIKE CHEMOTHERAPY FOR PREVIOUSLY UNTREATED GERMINAL CENTER B-CELL-LIKE MYC/BCL2 DOUBLE-EXPRESSER DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Wenyu Li, 421803
CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN AGGRESSIVE B-CELL LYMPHOMA OF CENTRAL NERVOUS SYSTEM (CNS): RESULTS FROM A RETROSPECTIVE ANALYSIS
EHA Library, Georg-Nikolaus Franke, 421804
INCORPORATING RADIATION WITH CAR T-CELL THERAPY  DEMONSTRATED A HIGH RATE OF REMISSION IN PATIENTS WITH B CELL LYMPHOMA INVOLVING THE CNS
EHA Library, Hui Shi, 421805
NUTRITIONAL STATUS AND INFLUENCING FACTORS ANALYSIS OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES DURING TRANSPLANT COMBINED WITH CAR-T CELL IMMUNOTHERAPY
EHA Library, yabin wang, 421806
A PHASE 1/2 TRIAL INVESTIGATING SAFETY, TOLERABILITY, AND PRELIMINARY ANTITUMOR ACTIVITY OF IPH6501, A FIRST-IN-CLASS NK CELL ENGAGER, IN PATIENTS WITH R/R CD20-EXPRESSING NHL
EHA Library, Lorenzo Falchi, 421807
TRIAL IN PROGRESS: PHASE 1 STUDY OF ARV-393, A PROTAC BCL6 DEGRADER, IN ADVANCED NON-HODGKIN LYMPHOMA
EHA Library, Paolo F Caimi, 421809
R-CHOP+X REGIMEN ACHIEVES HIGH RESPONSE RATE AND LONG-TERM SURVIVAL BENEFIT IN THE TREATMENT OF BN2 AND MCD SUBTYPES OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Tingting Chen, 421811
REAL-WORLD 7-YEAR SINGLE-CENTER EXPERIENCE IN THE MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
EHA Library, Vojin Vukovic, 421813
HBV ANTIGEN HBX PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA CHEMORESISTANCE THROUGH THE NF-KB/XIAP PATHWAY
EHA Library, Zhumei Zhan, 421814
EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN AND PREDNISONE IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: A REAL-WORLD STUDY IN CHINA
EHA Library, Yuhong Ren, 421815
EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINIB COMBIDED WITH RITUXIMAB AND LENALIDOMIDE FOR REFRACTORY RECURRENT AND NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA IN THE ELDELY
EHA Library, Chunxia Zhang, 421816
R-CHOP VERSUS DOSE-ADJUSTED-EPOCH-R AS A FIRST LINE THERAPY IN DOUBLE EXPRESSOR DLBCL A SINGLE CENTER EXPERIENCE
EHA Library, Sofija Pantelic, 421817
TOXICITY PROFILE OF THE LMB01 PROTOCOL IN THE TREATMENT OF PATIENTS WITH BURKITT LYMPHOMA
EHA Library, rihab ben sghaier, 421818
PREVALENCE AND TOXICITY MANAGEMENT OF CD20XCD3 BISPECIFIC  ANTIBODIES FOR B-CELL LYMPHOMAS IN THE STANDARD OF CARE SETTING
EHA Library, Ning Dong, 421819
PROGNOSTIC SIGNIFICANCE OF Β2-MICROGLOBULIN IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Rukesh Yadav, 421820
COMPARISON OF [18F]FDG OR [18F]FET PET WITH MRI FOR RESPONSE EVALUATION IN PRIMARY CNS LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE METHOTREXATE-BASED REGIMEN
EHA Library, Minyoung Oh, 421821
UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION CAN CURE A HIGH PERCENTAGE OF HIGH-INTERMEDIATE/HIGH-RISK AGGRESSIVE LYMPHOMA:  RESULTS OF A MONOCENTRIC RETROSPECTIVE SERIES
EHA Library, Alessandra Tucci, 421822
EARLY PROGRESSION AS A PREDICTOR OF SURVIVAL IN HODGKIN AND B-CELL NON HODGKIN LYMPHOMA, IN THE REAL WORLD: THE UKRAINIAN LYMPHOMA REGISTRY-BASED STUDY.
EHA Library, Nazar Shokun, 421823
TREATMENT WITH BISPECIFIC ANTIBODIES IN PATIENT WITH RELAPSED / REFRACTORY NON-HODGKIN LYMPHOMA (NHL)
EHA Library, Barbara Dreta, 421824
INFUSION-RELATED REACTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS TREATED WITH TWO RITUXIMAB BIOSIMILARS: SINGLE CENTER EXPERIENCE
EHA Library, Vojin Vukovic, 421825
CELL-FREE DNA LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Tatyana Rybolovleva, 421826
REAL LIFE EXPERIENCE FROM A SINGLE UNIT IN GREECE: EXCELLENT OUTCOME FOR MANTLE CELL LYMPHOMA (MCL) COMPARED TO DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH CAR T CELL THERAPY
EHA Library, Eleni Siavou, 421827
RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: IS SECOND-LINE IMMUNOCHEMOTHERAPY STILL A CHOICE?
EHA Library, Rita Azevedo Costa Sousa, 421828
AGGRESSIVE T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL DOUBLE-NEGATIVE CD4- CD8- TCRΑΒ+ IMMUNOPHENOTYPE
EHA Library, Angeliki Kotsiafti, 421829
THERAPEUTIC RESULTS OF ADULT’S LYMPHOBLASTIC LYMPHOMA
EHA Library, Hana BEN HAMMAMIA, 421830
OUTCOMES IN BURKITT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER SOLID ORGAN TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
EHA Library, Daniel Gil-Alós, 421831
EFFICACY AND SAFETY OF POLATUZUMAB VEDOTIN IN DIFFUSE LARGE B-CELL LYMPHOMA:A SINGLE-CENTER REAL-WORLD ANALYSIS FROM CHINA
EHA Library, Haiyan Yang, 421832
EVALUATION OF OVERALL SURVIVAL AND TOXICITY IN PATIENTS WITH BURKITT LYMPHOMATREATED WITH BURKIMAB 13 PROTOCOL
EHA Library, Ana Romina Montivero, 421833
CEREBROSPINAL FLUID INVESTIGATION IN DIFFUSE LARGE B-CELL LYMPHOMAS AT DIAGNOSIS.
EHA Library, Luigi Rigacci, 421834
A STUDY OF THE RELATIONSHIP BETWEEN CIRCULATING CYTOKINES (INTERLEUKIN-2 RECEPTOR AND TUMOR NECROSIS FACTOR RECEPTOR 2) AND RISK OF B-CELL NON-HODGKIN LYMPHOMA
EHA Library, Sara El-sayed, 421835
CNS PROPHYLAXIS IN PATIENTS WITH DLBCL: A REAL WORLD EXPERIENCE ON BEHALF OF THE LYMPHOMA SUBCOMMITTEE OF THE ARGENTINE SOCIETY OF HEMATOLOGY
EHA Library, Fernando Warley, 421836
DOSE ADJUSTED R-EPOCH IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA DURING PREGNANCY
EHA Library, Yana MANGASAROVA, 421837
EXAMINING THE TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA:  AN INTERNATIONAL MULTICENTER LONG TERM CLINICAL STUDY
EHA Library, Maria Kingsley-Godwin, 421838
EFFICACY OF DA-EPOCH IN PERIPHERAL T-CELL LYMPHOMAS
EHA Library, Rishabh Jain, 421839
COMPARATIVE ANALYSIS OF BLOOD PARAMETER KINETICS IN PATIENTS TREATED WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES
EHA Library, Elina Beleva, 421840
OVERALL SURVIVAL (OS) AND REAL-WORLD OVERALL RESPONSE RATE (ORR) OF DIFFUSE LARGE B-CELL LYMPHOMA WITH POLATUZUMAB VEDOTIN-BASED THERAPY, A MULTICENTRIC STUDY IN MEXICO
EHA Library, Silvia Margarita Rodriguez Mejorada, 421841
GOLSEEK-1: A PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF GOLCADOMIDE PLUS R-CHOP VS R-CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED, HIGH-RISK, LARGE B-CELL LYMPHOMA
EHA Library, Theodoros Vassilakopoulos, 421842
POLA-R-CHP FOR DIFFUSE LARGE B CELL LYMPHOMA WITH HIGH EXPRESSION OF P53 PROTEIN
EHA Library, Xia Zhao, 421843
SINGLE CENTER EXPERIENCE OF DA-EPOCH-R AS FRONTLINE TREATMENT FOR AGGRESSIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
EHA Library, Eugenia Montanari, 421844
THERAPEUTIC RESULTS OF DIFFUSE LARGE B CELL LYMPHOMA, GELT 2A GROUP
EHA Library, Aicha Ben kahla, 421845
ELEVATED BLOOD LACTATE LEVELS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): CLINICAL AND LABORATORY CORRELATIONS
EHA Library, Theodoros Vassilakopoulos, 421846
OPTIMALLY DELIVERED R-DA-EPOCH VERSUS R-CHOP IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A REAL-LIFE COMPARISON WITH HISTORICAL CONTROLS IN A SINGLE CENTER
EHA Library, Theodoros Vassilakopoulos, 421847
THE IMPACT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TO OVERALL SURVIVAL IN T CELL LYMPHOMA: A SINGLE-CENTER EXPERIENCE
EHA Library, Hsieh-Ting Lin, 421848
INVESTIGATING THE OUTCOMES IN PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH CENTRAL NERVOUS SYSTEM PROPHYLAXIS:  AN INTERCONTINENTAL MULTICENTRE CLINICAL STUDY
EHA Library, Daniella Kingsley-Godwin, 421849
STUDY OF THE ROLE OF BCL7A AND ITS MUTATIONS IN DLBCL
EHA Library, Pablo Martín López, 421850
SPI1 IS THE MASTER REGULATOR OF THE SMALL TUMOR CELLS IN THE SMALL CELL VARIANT OF ANAPLASTIC LARGE CELL LYMPHOMA
EHA Library, Kazuhiro Noguchi, 421852
THE CAUSAL EFFECT OF FOUR TYPES OF AUTOIMMUNE DISEASES ON SIX LYMPHOMAS SUBTYPES: A TWO-SAMPLE MENDELIAN RANDOMIZATION STUDY
EHA Library, Liang Wang, 421853
DISTINCT INTRATUMORAL MICROBIOME SIGNATURES ENRICHMENT IN PATIENTS WITH DIFFERENT ANAPLAPLASTIC LARGE CELL LYMPHOMA (ALCL) SUBTYPES.
EHA Library, Paola Ghione, 421854
PHOSPHO-EIF4E IS REQUIRED FOR NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN A MURINE MODEL OF EXTRANODAL LYMPHOMA.
EHA Library, Madelyn Abraham, 421855
TAFASITAMAB IN COMBINATION WITH METRONOMIC VINORELBINE AND ETOPOSIDE IS HIGHLY ACTIVE IN DIFFUSE LARGE B-CELL LYMPHOMA, A PRECLINICAL STUDY
EHA Library, M. C. Cox, 421856
TO EXPLORE THE EFFECT AND MECHANISM OF ZANUBRUTINIB, LENALIDOMIDE, TEMOZOLOMIDE IN THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
EHA Library, Zhaoyun Liu, 421857
ACT001 INHIBITS PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TUMOR GROWTH BY ENHANCING THE ANTI-TUMOR EFFECT OF T CELLS
EHA Library, Zhaoyun Liu, 421858
CHIDAMIDE ENHANCES T-CELL-MEDIATED ANTI-TUMOR IMMUNE FUNCTION BY INHIBITING NOTCH1/NFATC1 SIGNALING PATHWAY IN ABC-TYPE DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Li LI, 421859
THE GUT MICROBIOTA DIVERSITY IN PATIENTS WITH LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES DIFFERS SIGNIFICANTLY BETWEEN THERAPY RESPONDERS AND NONRESPONDERS
EHA Library, Lucie Dlouha, 421860
CIRCULATING TUMOR DNA AS CLONAL EVOLUTION IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Guilherme Duffles, 421861
UNVEILING PEMBROLIZUMAB'S PROMISE: A JOURNEY THROUGH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AND PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA
EHA Library, Aya Zaouali Dridi, 421862
EZH2 MUTATIONS AT DIAGNOSIS IN FOLLICULAR LYMPHOMA MAY BE USED AS A BIOMARKER TO GUIDE FRONTLINE TREATMENT: VALIDATION COHORT RESULTS.
EHA Library, Mariana Bastos-Oreiro, 421863
COMBINED APPLICATION OF LABORATORY PROGNOSTIC INDEX, PET-BASED RADIOMICS AND TRANSCRIPTOMICS IN DIFFUSE LARGE B-CELL LYMPHOMA: DOES IT HAVE ANY IMPACT ON THE EARLY DETECTION OF ‘NON-RESPONDERS’?
EHA Library, Santiago Browne Arthur, 421864
LOSS OF CD20 IS ASSOCIATED WITH POOR OUTCOME IN RELAPSE/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, thomas Hueso, 421865
APPLICATION OF COMPARATIVE PROTEOMIC AND BIOINFORMATIC ANALYSIS IN MYCOSIS FUNGOIDES PATIENTS REVEALS NOVEL POTENTIAL SERUM BIOMARKERS FOR EARLY DIAGNOSIS, PROGNOSIS AND STAGING
EHA Library, Smaragda Effraimidou, 421866
REGULATORY T CELLS (TREG) AND FOLLICULAR T CELLS (TF) IN LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTROM'S MACROGLOBULINEMIA (LPL
EHA Library, Mafalda Urbano, 421867
FASCIN EXPRESSION PROFILING IN LYMPHOMA: IMPLICATIONS FOR TARGETED THERAPY AND TREATMENT RESISTANCE
EHA Library, Ana Belén Arroyo-Rodríguez, 421868
PROGNOSTIC VALUE OF THE PROPORTION INDEX OF TUMOR CELLS EXPRESSING P16INK4A AND P14ARF IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Maria Sarpova, 421869
CYTOKINE MEDIATED CROSSTALK IN ALK+ ALCL AND TUMOUR ASSOCIATED MACROPHAGES
EHA Library, Rebekka Salzmann, 421870
THE PROGNOSTIC IMPLICATIONS OF THE CRP/ALBUMINE RATIO IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, IN RESOURCE-CONSTRAINED NATIONS
EHA Library, Ahlem Slama, 421871
EXPANDING B-CELL LYMPHOMA GENETIC CHARACTERIZATION VIA CELL SORTING PRIOR TO NEXT-GENERATION SEQUENCING AND FISH ANALYSIS
EHA Library, Veronika Ecker, 421872
MYD88 L265P ON CIRCULATING TUMOR DNA FOR WALDENSTRÖM DIAGNOSIS
EHA Library, Léa Ryffel, 421873
CINOBUFAGIN: A PROMISING NATURAL G6PD INHIBITOR FOR POTENTIAL THERAPEUTIC STRATEGIES IN DLBCL
EHA Library, Sanxiu He, 421874
PLASMA EXTRACELLULAR VESICLE RNA PROFILING AND DECONVOLUTION FOR OUTCOME PREDICTION IN LARGE B-CELL LYMPHOMA
EHA Library, Steven Wang, 421875
THE CHROMATIN REMODELING HELLS: THE MISSING LINK BETWEEN TRANSCRIPTION AND GENOME STABILITY IN T-CELL LYMPHOMA
EHA Library, Valentina Fragliasso, 421876
PCLAF DRIVES THE RESISTANCE AGAINST PEVONEDISTAT IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Xin Wang, 421877
TARGETING IRON HOMEOSTASIS WITH IRONOMYCIN AS A THERAPEUTIC STRATEGY IN MANTLE CELL LYMPHOMA
EHA Library, Sara Ovejero, 421879
HEIGHTENED GENETIC SUSCEPTIBILITY TO GLUTEN IN B-CELL LYMPHOPROLIFERATIVE DISORDERS WITH SECONDARY IMMUNODEFICIENCY
EHA Library, María Palacios-Ortega, 421880
USE OF OPTICAL GENOME MAPPING IN THE CYTOGENETIC DIAGNOSIS OF LYMPHOMA
EHA Library, Andrea Gutierrez, 421881
INVESTIGATION OF THE DLBCL TUMOUR MICROENVIRONMENT USING CIBERSORT
EHA Library, Stephen Power, 421882
EFFICACY AND SAFETY OF A NOVEL ANTI-CD20 AGENT “RIPERTAMAB (SCT400)” -BASED CHEMOTHERAPY IN PATIENTS WITH CD20-POSITIVE B-NHL: A MULTI-CENTER, RETROSPECTIVE, REAL-WORLD STUDY IN CHINA
EHA Library, Jun Li, 421883
LSD1 INHIBITION INCREASES THE ANTIGEN PRESENTING CAPACITY OF AML BLASTS
EHA Library, Sarah Charrot, 421884
ASSESSMENT OF THE PRACTICAL INFORMATIVITY OF A MULTIPLEX SHORT TANDEM REPEATS (STR) ASSAY FOR POST HAPLOIDENTICAL STEM CELL TRANSPLANTATION MONITORING
EHA Library, Gee Fung How, 421885
IPSC-DERIVED HEMATOPOIETIC CELLS IN Β-THALASSEMIA: FROM GENERATION TO THERAPEUTIC POTENTIAL
EHA Library, Maliha Javed, 421886
GUT MICROBIOTA EFFECT ON IMMUNOSUPPRESSIVE THERAPY IN PATIENTS AFTER ALLO-HSCT
EHA Library, Mikhail Uss, 421887
RESEARCH ON THE IMPACT OF THE IMMUNE ENVIRONMENT AFTER G-CSF MOBILIZATION OF DONORS AND THE PROGNOSIS OF PATIENTS AFTER ALLO-HSCT
EHA Library, Hui Wang, 421888
ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS IN THE PREDICTION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES
EHA Library, Arsa Thammahong, 421889
EFFECT OF DIFFERENT METHODS OF CYCLOSPORINE APPLICATION ON ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN SEVERE APLASTIC ANAEMIA(SAA)PATIENTS
EHA Library, Tao Wang, 421890
LETERMOVIR FOR SECONDARY PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
EHA Library, Nihar Desai, 421891
PROGNOSTIC FACTORS FOR ALLO-HSCT IN ADVANCED AGE: A RETROSPECTIVE LONG TERM ANALYSIS
EHA Library, Ajda GUNES, 421892
INFUSION OF HAEMATOPOIETIC STEM CELLS THROUGH PERIPHERALLY INSERTED CENTRAL CATHETERS WITH VOLUMETRIC PUMPS DOES NOT AFFECT ENGRAFTMENT IN ADULT RECIPIENTS
EHA Library, Khushnuma Mullanfiroze, 421893

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings